SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-029043
Filing Date
2021-08-20
Accepted
2021-08-20 16:55:58
Documents
15
Period of Report
2021-08-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10028249_8k.htm   iXBRL 8-K 43365
2 EXHIBIT 99.1 brhc10028249_ex99-1.htm EX-99.1 14229
7 image00001.jpg GRAPHIC 7046
  Complete submission text file 0001140361-21-029043.txt   272098

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mrk-20210819.xsd EX-101.SCH 5154
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20210819_def.xml EX-101.DEF 19223
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20210819_lab.xml EX-101.LAB 29837
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20210819_pre.xml EX-101.PRE 21630
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc10028249_8k_htm.xml XML 11122
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 211194425
SIC: 2834 Pharmaceutical Preparations